| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |